Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. - Wikidata - awgldk - TriplyDB

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

http://www.wikidata.org/entity/Q46095343

about

Acupuncture for treatment of irritable bowel syndrome Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation.How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.Pain symptoms and stooling patterns do not drive diagnostic costs for children with functional abdominal pain and irritable bowel syndrome in primary or tertiary care Role of antispasmodics in the treatment of irritable bowel syndrome.An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndrome Impact of functional gastrointestinal disorders on survival in the community.Recent advances in pharmacological treatment of irritable bowel syndrome.Irritable bowel syndrome: a clinical review Acupuncture for irritable bowel syndrome: systematic review and meta-analysis Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.Bloating and functional gastro-intestinal disorders: where are we and where are we going?A protocol for a trial of homeopathic treatment for irritable bowel syndrome.Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis.Latent structure of irritable bowel syndrome symptom severity.A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations.Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls Health care seeking for abdominal bloating and visible distention Optimal management of constipation associated with irritable bowel syndrome Functional gastrointestinal disorders in African American children in primary care.The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis Irritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study.Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study.An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.Review of tegaserod in the treatment of irritable bowel syndrome.Avoiding unnecessary surgery in irritable bowel syndrome.Review article: epidemiology and quality of life in functional gastrointestinal disorders.Variation in Care for Patients with Irritable Bowel Syndrome in the United States.Irritable bowel syndrome: physicians' awareness and patients' experience New and Emerging Treatment Options for Irritable Bowel Syndrome.

P2860

Q24197693-64E7F406-8A30-48D4-9046-4EE2F0D68063 Q24234934-EFDC0C4D-CD00-4813-8C90-D9A8C315DC6F Q26744329-C0F3A60E-5B46-4D62-9DD3-04170F8B8C57 Q30724990-5B89A811-6F67-474D-AF5B-102134A25E00 Q33451900-067B6D45-9C0C-47E6-9172-FB2FD4C60F21 Q33466527-9EDA10F5-5C87-4F3C-884F-8E373CC7D63B Q33527597-820F51B5-6D30-4B3F-A8EB-D3F1DF0DECC9 Q33541333-0184FF2E-4B44-4C3B-AEFA-6D5204DC016D Q33651581-9497B76A-B4AE-47B8-8792-08AD5E58C191 Q33661077-30015B18-A5A5-4C24-A536-C939C3389946 Q33667183-2079E742-9DF6-4015-A71A-ED49E4D40C1A Q33795765-4562579D-8534-481A-A639-6FB5E9904013 Q33919405-69FBE41A-6B33-410E-8C16-1E41DEDCE8B1 Q33958853-CE34C7A5-1712-4F1F-88C5-C807750654A8 Q34168517-5EF74935-076E-4EC4-8FC5-5CE6506CB105 Q34266907-C36B558B-9552-4344-BB98-D003DA6CBB8B Q34309302-7A89B59D-3C6C-4C96-A8F9-2F6F18D4AA71 Q34366956-A684AD78-2302-4517-90E6-9074148E8007 Q34468338-FCDD1D8C-5025-4162-A2CD-5DCF7397797F Q34473834-3E594582-B042-4434-A3B0-F295D7DC5CCE Q34626602-F93C5405-B57B-4FA8-97BE-74140A347CE4 Q34660809-516F5E03-3E8E-4143-B8B0-7F9DDE007711 Q34827497-ABC97E7C-D815-4F80-A398-494A4167FD12 Q35000565-E1739261-1C9B-40D2-B9B3-3D9EE40D0859 Q35061903-E1739E46-3FF3-4361-ADA6-1E38337CF6E0 Q35155933-56A3B210-4349-46EA-8EFF-FF6986CFCD5D Q35268912-F74141ED-353A-4CAC-A55A-5D29D084D72B Q35553123-25CD4F38-53AB-4933-846D-AA862BC42C90 Q35586543-12282793-5905-4593-8A87-0EBC3D30DF18 Q35596365-871B6868-F6AB-44D6-BFA9-0F0575178DA9 Q35755340-64E028C5-2776-4810-9061-FAF006A1E09D Q35885500-E05D0DD8-3F4D-48F2-8D1B-9C78FE51003B Q35910817-961DEAAC-8906-46C8-BF75-09DB273AD08A Q35917169-2A568611-B00C-4E51-A02C-6849AC2CD089 Q35925555-D19742D8-B79D-469C-B4FE-B0C38C155465 Q35929485-5478864C-7498-4EE7-A99D-B13DCE3912BF Q35936950-DDCACE06-335F-42DA-B000-04E50744D7A8 Q35999802-39325970-DD28-4029-AB3E-57B795B0A369 Q36121234-16E92DE6-B0A6-449E-AD62-A87CB518F188 Q36180769-A01AEE56-2ED6-48A4-BE85-B2E33ADF18D5

P2860

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

http://www.wikidata.org/entity/Q46095343

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@en

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@nl

type

label

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@en

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@nl

prefLabel

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@en

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@nl

P1433

Q46095343-32134631-0B53-4B8C-9993-A1936200DDFF

P1476

Q46095343-87D12D50-647F-4588-9422-4DC92F58511E

P2093

Q46095343-0F70D1D9-3102-4130-8EBC-F22AAF61A471

Q46095343-2864259D-66B7-4F1C-8385-11F2E8312E95

Q46095343-88BD085C-0CAC-4041-8101-0E62A564B19C

Q46095343-BFFAA4E2-1BDC-46EF-87FC-4A60DCDE8736

Q46095343-C8D7EF58-BCB4-4AED-9067-9144A9B50DB5

Q46095343-E50E781E-C6D1-4377-B832-79411667EDAA

Q46095343-EEFE1925-5753-45F6-9ADE-78EFFCC47A96

Q46095343-F7D4ED88-E849-4FE1-9C78-994422B05517

P2860

Q46095343-0720A03E-4DF3-4B7E-A164-8D331C32E4FA

Q46095343-529CE9ED-C30E-4431-8F82-F5453D96B7E8

Q46095343-81E3A77C-CDE4-4730-B851-1EE6AD0C83FB

Q46095343-A17AFCA0-CDC2-4061-92EE-70546459C439

Q46095343-B1B85BB0-EA98-4BD3-AF4C-712E75AC0573

P304

Q46095343-A4EBBBBA-ACE3-4082-A562-80B169BF25DF

P31

Q46095343-706109E7-A2EA-4013-9627-8A5ECCDB814E

P356

Q46095343-87B7D994-7DF5-4928-B800-580BED902BF0

P407

Q46095343-58D69355-43FD-4091-8FB4-8D18EE2E5164

P433

Q46095343-8B76989E-4C32-4BED-8D4A-758E7FD52437

P478

Q46095343-D84F7640-9E74-4F6C-8BF3-8560B974B641

P577

Q46095343-97EB208D-18D1-433E-B056-59965DFC9A6C

P698

Q46095343-2443AF01-4F5F-4DAE-BE9B-7CD3B4BCE964

P356

J.1572-0241.2003.07296.X

P1433

The American Journal of Gastroenterology

P1476

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

@en

P2093

Alisa Wilson

http://www.w3.org/2001/XMLSchema#string

Chiun-Fang Chiou

http://www.w3.org/2001/XMLSchema#string

Feride Frech

http://www.w3.org/2001/XMLSchema#string

George F Longstreth

http://www.w3.org/2001/XMLSchema#string

John Wong

http://www.w3.org/2001/XMLSchema#string

Joshua J Ofman

http://www.w3.org/2001/XMLSchema#string

Kevin Knight

http://www.w3.org/2001/XMLSchema#string

Victoria Barghout

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome

Costs of care for irritable bowel syndrome patients in a health maintenance organization.

Recovery from depression, work productivity, and health care costs among primary care patients.

Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population.

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

P304

600-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2003.07296.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12650794

http://www.w3.org/2001/XMLSchema#string